CIMware’s breakthrough in composable infrastructure might very well be the foundational technology that will power the next generation of AI and cloud computing worldwide!

What is the news?

  • CIMware, founded by Rajiv Ganth in 2022, has raised $2.3 million in pre-Series A funding led by Transition VC to scale hardware production, R&D, and global market operations for its revolutionary data center technology.
  • The startup has developed the patented Composable Infrastructure Module (CIM), a smart switching device that combines compute, storage, and networking into a single rack-level unit, enabling modular deployment and dramatically more energy-efficient architecture for AI, ML, social media, and video streaming workloads.

Why is it interesting?

  • This is infrastructure innovation at a massive scale. CIMware’s technology slashes total cost of ownership by 80% and reduces carbon footprint while enabling modular upgrades, making it ideal for public, private, and edge cloud environments. Their memory-as-interconnect backbone approach represents a fundamental departure from traditional server-centric design.
  • With multiple patents developed entirely in India and initial production of 20 CIM units scheduled for December 2025 deployment, they’re targeting 80-100 units initially before scaling to thousands. Active talks with data centers in South Korea, the US, and the UK demonstrate global validation of their approach.
  • Its go-to-market strategy includes direct sales in India and North America, white-labeled deployments in Southeast Asia, and affiliate-driven expansion in Europe.
  • Market timing and founder pedigree are exceptional. Ganth previously led CloudSimple India (acquired by Google) and held senior engineering roles at Intel, EMC, LSI, and DEC.
  • With data centers becoming increasingly power and energy hungry due to AI demand, CIMware’s solution addresses critical infrastructure modernization needs with a targeted revenue milestone of $175 million by fiscal 2026-27.

Read more: Innovation-led biopharma startup Lamark Biotech raises Rs 6.5 crore in funding